Fig. 1From: AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cyclesStudy Flow Chart. aThis visit should occur on the same day as the last visit of the previous treatment cycle. Re-treatment was expected to occur approximately 12–16 weeks after the last treatment; however, the exact timing of treatment was determined by the investigator based on clinical need. bPatients who withdrew from the study early (ie, before week 12 of cycle 3) underwent all procedures required for the week 36 visitBack to article page